FMP
Hyloris Pharmaceuticals SA
HYL.BR
EURONEXT
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was incorporated in 2012 and is headquartered in Liège, Belgium.
11.7 EUR
-0.15 (-1.28%)
About
ceo
Mr. Jean-Luc Vandebroek
sector
Healthcare
industry
Biotechnology
website
https://hyloris.com
exchange
EURONEXT
Description
Hyloris Pharmaceuticals SA engages in the develop, manufacture, and deliver pharmaceutical products to address unmet medical needs in cardiovascular health, oncology, women's health, and other major therapeutic areas. The company offers cardiovascular products for atrial fibrillation, acute coronary syndrome, advanced heart failure, congestive heart failure, acute coronary syndrome, and coronary heart disease. It also provides other products, such as post operation pain, dental indications, severe and recurring vulvovaginal candidiasis, acute myeloid leukemia and small cell lung cancer, IC/PBS, attention deficit hyperactivity disorder, and viral infection. Hyloris Pharmaceuticals SA was inco...
CIK
N/A
ISIN
BE0974363955
CUSIP
N/A
Address
Boulevard Gustave Kleyer 17
Phone
32 4 346 02 07
Country
BE
Employee
40
IPO Date
Jun 29, 2020
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
BE0974363955
Country
BE
Price
11.7
Beta
0.58
Volume Avg.
11.29k
Market Cap
327.6M
Shares
-
52-Week
10.6-14.1
DCF
-7.21
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-20.89
P/B
-
Website
https://hyloris.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HYL.BR News
It looks like there's no news available.
